Journal of Stem cell Research and Therapy
Awards Nomination
10+ Million Readerbase
Google Scholar citation report
Indexed In
Open J Gate Genamics JournalSeek RefSeek Hamdard University EBSCO A-Z OCLC- WorldCat Publons Geneva Foundation for Medical Education and Research Euro Pub Google Scholar
Journal Highlights
Stem Cell Niche and Microenvironment
Pluripotent Stem Cells and Reprogramming
ImmunoMSC
Stem Cell-Based Regenerative Therapies
Organoids and 3D Stem Cell Cultures
Stem Cell Gene Editing and CRISPR
Hematopoietic Stem Cell Transplantation HSCT
Cancer Stem Cells and Tumorigenesis
Ethical, Regulatory, and Translational Issues
Biomaterial Support for Stem Cell Growth
Pluripotent Stem Cells and Reprogramming
ImmunoMSC
Stem Cell-Based Regenerative Therapies
Organoids and 3D Stem Cell Cultures
Stem Cell Gene Editing and CRISPR
Hematopoietic Stem Cell Transplantation HSCT
Cancer Stem Cells and Tumorigenesis
Ethical, Regulatory, and Translational Issues
Biomaterial Support for Stem Cell Growth
Useful Links
Recommended Journals
Open Access Journals
Journal of Mental Health and Psychiatry
Journal of Cancer Chemotherapy
Journal of Pediatrics Neonatal Biology
Journal of Endocrinology
Journal of Women Health
Journal of Medicinal Chemistry
Journal of Drug Discovery and Research
Journal of Dental Sciences
Journal of Bacteriology Parasitology
Journal of Biology and Medicine
Journal of Fermentation Technology
Journal of Plant Pathology
Journal of Stem cell Research and Therapy
Ethical, Regulatory, and Translational Issues
Ethical, regulatory, and translational issues play a critical role in stem cell research and its clinical applications. Ethical concerns often revolve around the source of stem cells, particularly embryonic stem cells, and informed consent from donors. Regulatory frameworks ensure the safety, efficacy, and quality of stem cell-based therapies before human use. Translational challenges include bridging the gap between laboratory findings and real-world clinical treatments. Navigating these issues is essential for responsible innovation and public trust in regenerative medicine.